These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 20410833

  • 1. Pharmacological inhibition of cathepsin S decreases atherosclerotic lesions in Apoe-/- mice.
    Samokhin AO, Lythgo PA, Gauthier JY, Percival MD, Brömme D.
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):98-105. PubMed ID: 20410833
    [Abstract] [Full Text] [Related]

  • 2. Destabilizing role of cathepsin S in murine atherosclerotic plaques.
    Rodgers KJ, Watkins DJ, Miller AL, Chan PY, Karanam S, Brissette WH, Long CJ, Jackson CL.
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):851-6. PubMed ID: 16410454
    [Abstract] [Full Text] [Related]

  • 3. Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice.
    Samokhin AO, Wong A, Saftig P, Brömme D.
    Atherosclerosis; 2008 Sep; 200(1):58-68. PubMed ID: 18291403
    [Abstract] [Full Text] [Related]

  • 4. Cholate-containing high-fat diet induces the formation of multinucleated giant cells in atherosclerotic plaques of apolipoprotein E-/- mice.
    Samokhin AO, Wilson S, Nho B, Lizame ML, Musenden OE, Brömme D.
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1166-73. PubMed ID: 20203298
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.
    de Nooijer R, Bot I, von der Thüsen JH, Leeuwenburgh MA, Overkleeft HS, Kraaijeveld AO, Dorland R, van Santbrink PJ, van Heiningen SH, Westra MM, Kovanen PT, Jukema JW, van der Wall EE, van Berkel TJ, Shi GP, Biessen EA.
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):188-94. PubMed ID: 19095996
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment.
    Johnson J, Carson K, Williams H, Karanam S, Newby A, Angelini G, George S, Jackson C.
    Circulation; 2005 Mar 22; 111(11):1422-30. PubMed ID: 15781753
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S, Matoba T, Umezu R, Koga J, Tokutome M, Katsuki S, Nakano K, Sunagawa K, Egashira K.
    Arterioscler Thromb Vasc Biol; 2016 Mar 22; 36(3):491-500. PubMed ID: 26821947
    [Abstract] [Full Text] [Related]

  • 11. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.
    Lutgens E, Lutgens SP, Faber BC, Heeneman S, Gijbels MM, de Winther MP, Frederik P, van der Made I, Daugherty A, Sijbers AM, Fisher A, Long CJ, Saftig P, Black D, Daemen MJ, Cleutjens KB.
    Circulation; 2006 Jan 03; 113(1):98-107. PubMed ID: 16365196
    [Abstract] [Full Text] [Related]

  • 12. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis.
    Johnson JL, Baker AH, Oka K, Chan L, Newby AC, Jackson CL, George SJ.
    Circulation; 2006 May 23; 113(20):2435-44. PubMed ID: 16702468
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.
    Johnson JL, George SJ, Newby AC, Jackson CL.
    Proc Natl Acad Sci U S A; 2005 Oct 25; 102(43):15575-80. PubMed ID: 16221765
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
    Madrigal-Matute J, López-Franco O, Blanco-Colio LM, Muñoz-García B, Ramos-Mozo P, Ortega L, Egido J, Martín-Ventura JL.
    Cardiovasc Res; 2010 May 01; 86(2):330-7. PubMed ID: 20154064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability.
    Johnson JL, Fritsche-Danielson R, Behrendt M, Westin-Eriksson A, Wennbo H, Herslof M, Elebring M, George SJ, McPheat WL, Jackson CL.
    Cardiovasc Res; 2006 Aug 01; 71(3):586-95. PubMed ID: 16759648
    [Abstract] [Full Text] [Related]

  • 19. AT1 blockade attenuates atherosclerotic plaque destabilization accompanied by the suppression of cathepsin S activity in apoE-deficient mice.
    Sasaki T, Kuzuya M, Nakamura K, Cheng XW, Hayashi T, Song H, Hu L, Okumura K, Murohara T, Iguchi A, Sato K.
    Atherosclerosis; 2010 Jun 01; 210(2):430-7. PubMed ID: 20079903
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice.
    Jormsjö S, Wuttge DM, Sirsjö A, Whatling C, Hamsten A, Stemme S, Eriksson P.
    Am J Pathol; 2002 Sep 01; 161(3):939-45. PubMed ID: 12213722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.